AFINITOR®(everolimus)

Prescribing Information


ATECTURA® BREEZHALER®(indacaterol (as acetate)/mometasone furoate)

Prescribing Information

AZARGA®(brinzolamide / timolol (as timolol maleate))

Prescribing Information

AZOPT®(brinzolamide)

Prescribing Information

BEOVU®(brolucizumab)

Prescribing Information

CATAFLAM®(diclofenac potassium)

Prescribing Information

CILOXAN®(ciprofloxacin hydrochloride)

Prescribing Information

CO-DIOVAN®(valsartan/hydrochlorothiazide)

Prescribing Information


DESFERAL®(deferoxamine mesilate)

Prescribing Information

DIOVAN®(valsartan)

Prescribing Information

DUOTRAV®(timolol maleate/travoprost)

Prescribing Information

ENERZAIR® BREEZHALER®(indacaterol/glycopyrronium/mometasone furoate)

Prescribing Information

ENTRESTO®(sacubitril/valsartan)

Prescribing Information

EUCREAS®(vildagliptin/metformin)

Prescribing Information

EXELON®(rivastigmine hydrogen tartrate)

Prescribing Information

EXELON® PATCH(rivastigmine)

Prescribing Information

EXFORGE®(amlodipine/valsartan)

Prescribing Information

EXFORGE® HCT(amlodipine/valsartan/hydrochlorothiazide)

Prescribing Information

EXJADE®(deferasirox)

Prescribing Information

FEMARA®(letrozole)

Prescribing Information

GALVUS®(vildagliptin)

Prescribing Information

GILENYA®(fingolimod)

Prescribing Information

GLIVEC®(imatinib)

Prescribing Information

JAKAVI®(ruxolitinib)

Prescribing Information



KYMRIAH®(tisagenlecleucel)

Prescribing Information

LAMISIL®(terbinafine)

Prescribing Information


LIORESAL®(baclofen)

Prescribing Information

LUCENTIS®(ranibizumab)

Prescribing Information

LUTATHERA®(lutetium)

Prescribing Information

LYSAKARE®(l-arginine/l-lysine)

Prescribing Information

MAXIDEX®(dexamethasone)

Prescribing Information

MAXITROL®(dexamethasone/polymyxin b sulfate/neomycin sulfate)

Prescribing Information

MAYZENT®(siponimod)

Prescribing Information


MYFORTIC®(mycophenolic acid)

Prescribing Information

NEORAL®(ciclosporin)

Prescribing Information

NEVANAC®(nepafenac)

Prescribing Information

ONBREZ® BREEZHALER®(indacaterol)

Prescribing Information

OPATANOL®(olopatadine (as hydrochloride))

Prescribing Information


RYDAPT®(midostaurin)

Prescribing Information

SANDIMMUN®(ciclosporin)

Prescribing Information

SANDOSTATIN®/SANDOSTATIN LAR®(octreotide)

Prescribing Information

SEEBRI® BREEZHALER®(glycopyrronium)

Prescribing Information

SIMBRINZA®(brinzolamide/brimonidine tartrate)

Prescribing Information

SIMULECT®(basiliximab)

Prescribing Information

SOMAKIT®(edotreotide)

Prescribing Information


TASIGNA®(nilotinib)

Prescribing Information

TEGRETOL®(carbamazepine)

Prescribing Information

TRAVATAN®(travoprost)

Prescribing Information

TRILEPTAL®(oxcarbazepine)

Prescribing Information

TYVERB®(lapatinib)

Prescribing Information

ULTIBRO® BREEZHALER®(indacaterol/glycopyrronium)

Prescribing Information

VOLTAROL®(diclofenac sodium)

Prescribing Information

VOTRIENT®(pazopanib)

Prescribing Information

XOLAIR®(omalizumab)

Prescribing Information

ZOFRAN®(ondansetron hydrochloride dihydrate)

Prescribing Information

ZOLGENSMA®(onasemnogene abeparvovec)

Prescribing Information

IE299338 | September 2023
×

Ask Speakers

×

Medical Information Request

Reporting of side effects
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance, website www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.